MSME drugmakers to face up to 5% profit pressure over West Asia hit | Collector
Business Standard
MSME drugmakers to face up to 5% profit pressure over West Asia hit
Prolonged West Asia disruptions are raising freight, raw material and energy costs, intensifying pressure on smaller Indian pharmaceutical manufacturers
Business Standard